Jovann, u are right. We are in a market segment that is growing, not diminishing.
Once people try the product, it is a better alternative.
Also license deals and international distribution will also re-rate. the company now has the funds to go for it. No more stumbling blocks, as all the boxes ticked...
Just when...
thermalife vs voltaren ?, page-4
Add CAI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CAI (ASX) Chart |
Day chart unavailable